SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001841401-23-000007
Filing Date
2023-12-01
Accepted
2023-12-01 16:55:53
Documents
3
Period of Report
2023-11-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1701467742.html 4  
1 FORM 4 wk-form4_1701467742.xml 4 7535
2 EX-24 secpoabryanwahl.htm EX-24 608
3 secpoabryanwahl001.jpg GRAPHIC 223886
  Complete submission text file 0001841401-23-000007.txt   317922
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618
Business Address
Wahl Bryan (Reporting) CIK: 0001841401 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 231460304